ANPI Angiotech Pharmaceuticals - Common Shares (MM)

THIRD QUARTER 2007 FINANCIAL RESULTS VANCOUVER, Oct. 25 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), a global specialty pharmaceutical and medical device company, will host a conference call discussing its financial results for the third quarter ended September 30, 2007. Thursday, November 1, 2007 at 11:00 AM ET (8:00 AM Pacific, 9:00 AM Mountain, 10:00 AM Central) Dial information is as follows: North America (toll-free): (800) 901-5213 International: (617) 786-2962 Enter passcode: 75137732 A live webcast will be available to all interested parties through Angiotech's website at http://www.angiotech.com/ in the Investor Relations section. A press release announcing Angiotech's financial results will be issued prior to the conference call at approximately 8:00 AM ET (5:00 AM Pacific, 6:00 AM Mountain, 7:00 AM Central). A replay archive of the conference call will be available until November 8, 2007. Replay information is as follows: North America: (888) 286-8010 International: (617) 801-6888 Enter passcode: 15190735 About Angiotech Pharmaceuticals Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ:ANPINASDAQ:TSXNASDAQ:ANP) please visit our website at http://www.angiotech.com/. CONTACT: Deirdre Neary, Manager, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 222-7056, ; Jodi Regts, Senior Manager, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7930, DATASOURCE: Angiotech Pharmaceuticals, Inc. CONTACT: Deirdre Neary, Manager, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 222-7056, ; Jodi Regts, Senior Manager, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7930,

Copyright